New Jersey Chapter Fights for Critical State Legislation
Stephanie Lapidow, Executive Director of the Hemophilia Association of New Jersey (HANJ), is leading the charge to protect patients from predatory insurance practices through critical state legislation (S-3818/A-5217).
Government Relations Update - February 2025
Tune In! NBDF's Bill Robie Talks HB 1216 & Rx Costs
🎙 Tune In! NBDF's Bill Robie Talks HB 1216 & Rx Costs
A Powerful BDAND Testimony in the Minot Daily News
Today, we're sharing a powerful letter from Emily Ouellette, Executive Director of the Bleeding Disorders Alliance of North Dakota (BDAND), featured on February 18, 2025, in the Minot Daily News.
Your Government Relations Update: January 2025
NBDF Advocates for Lower Out-of-Pocket Drug Costs in North Dakota
Government Relations Update - December 2024
Government Relations Update - November 2024
Federal
2024 Election & What to Expect for the End of the Year
Beginning in 2025 with the 119th Congress and the January 20th Presidential Inauguration, Republicans will take control of the White House and the two chambers of Congress, the Senate flippi
Government Relations Update - October 2024
Government Relations Update - September 2024
NovoNordisk Manufacturing Issue Affects Key Hemophilia Treatments
Unveiling Voices for Policy Change
Government Relations Update - August 2024
Government Relations Update - July 2024
Government Relations Update – July 2024
Federal
WTAE-TV Feature: Copay Accumulators – Who Really Benefits?
Government Relations Update - June 2024
Government Relations Updates May 2024
Washington Days 2024 Recap: Empowering the Bleeding Disorders Community
Government Relations Update - April 2024
Government Relations Update - February 2024
Government Relations Update – February 2024
Government Relations Update - January 2024
Government Relations Update - December 2023
Government Relations Update - November 2023
NBDF Government Relations Update - October 2023
Court Rules in Favor of Patients regarding Copay Accumulator Adjustor Programs
Government Relations Update - August & September 2023
Concerns Over Payer Matrix's Self-Identification as Patient Advocacy Company
Government Relations Update - June 2023
Government Relations Update - May 2023
Government Relations Update - April 2023
Coalition Advocates for Substance Use Disorder/Behavioral Health Services for Patients With Bleeding Disorders
Government Relations Update - March 2023
NHF Public Policy February Monthly Update
APLUS Coalition Members Unite to Issue New Joint Statement
Important Changes Coming to Your State Medicaid or CHIP Program
NHF & HFA Respond to New Blue Cross Blue Shield of Tennessee Formularies
NHF Addresses Potential Contraception Bans
All Copays Count Coalition Statement on Draft 2023 CMS Notice of Benefit and Payment Parameters
WASHINGTON, D.C.— December 31, 2021 — In response to additional rulemaking for the Centers for Medicare & Medicaid Services’ (CMS) Notice of Benefit and Payment Parameters (NBPP
NHF Applauds Newly Official Michigan Law That Repeals Tampon Tax
NHF Statement on HELP Copays Act
Media Contact:
Ilana Ostrin
212 328 3769
All Copays Count Coalition Applauds House Introduction of Help Ensure Lower Patient Copays Act
NHF Responds to STIMATE® Production Update
CSL Behring announced that the company’s distribution agreement with Ferring Pharmaceuticals for STIMATE® nasal spray recently expired and will not be renewed effectively removing this medication as a valuable treatment opti
NHF Responds to New CMS Guidance
Media Contact:
Brett Spitale, VP of Advancement
bspitale@hemophilia.org
646-784-0368
New Affordable Care Act Ruling Benefits Chronic Disease Patients
NHF Marks the 40th Anniversary of the HIV Epidemic
FOR PUBLIC COMMENT - JUNE 3, 2021
How the American Rescue Plan Can Affect Your Healthcare Coverage
ACA Marketplaces to Reopen
NHF Applauds Congressional Enactment of The Hemophilia SNF Access Act
The National Hemophilia Foundation is thrilled to announce that its top legislative priority in 2020, The Hemophilia SNF Access Act, was included in the end-of-year omnibus federal spending and economic relief package passed by Congress on December 21, 2020 (HR 133, The Consolidated Appropriation